Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Chaffanet, M"" wg kryterium: Wszystkie pola


Tytuł:
Prospective high-throughput genome profiling of advanced cancers: results of the PERMED-01 clinical trial.
Autorzy:
Bertucci F; Laboratory of Predictive Oncology, Department of Medical Oncology, Centre de Recherche en Cancérologie de Marseille (CRCM), Institut Paoli-Calmettes, INSERM UMR1068, CNRS UMR725, Aix-Marseille University, 232 Boulevard Sainte-Marguerite, 13009, Marseille, France. .; Department of Medical Oncology, Institut Paoli-Calmettes, Marseille, France. .
Gonçalves A; Laboratory of Predictive Oncology, Department of Medical Oncology, Centre de Recherche en Cancérologie de Marseille (CRCM), Institut Paoli-Calmettes, INSERM UMR1068, CNRS UMR725, Aix-Marseille University, 232 Boulevard Sainte-Marguerite, 13009, Marseille, France.; Department of Medical Oncology, Institut Paoli-Calmettes, Marseille, France.
Guille A; Laboratory of Predictive Oncology, Department of Medical Oncology, Centre de Recherche en Cancérologie de Marseille (CRCM), Institut Paoli-Calmettes, INSERM UMR1068, CNRS UMR725, Aix-Marseille University, 232 Boulevard Sainte-Marguerite, 13009, Marseille, France.
Adelaïde J; Laboratory of Predictive Oncology, Department of Medical Oncology, Centre de Recherche en Cancérologie de Marseille (CRCM), Institut Paoli-Calmettes, INSERM UMR1068, CNRS UMR725, Aix-Marseille University, 232 Boulevard Sainte-Marguerite, 13009, Marseille, France.
Garnier S; Laboratory of Predictive Oncology, Department of Medical Oncology, Centre de Recherche en Cancérologie de Marseille (CRCM), Institut Paoli-Calmettes, INSERM UMR1068, CNRS UMR725, Aix-Marseille University, 232 Boulevard Sainte-Marguerite, 13009, Marseille, France.
Carbuccia N; Laboratory of Predictive Oncology, Department of Medical Oncology, Centre de Recherche en Cancérologie de Marseille (CRCM), Institut Paoli-Calmettes, INSERM UMR1068, CNRS UMR725, Aix-Marseille University, 232 Boulevard Sainte-Marguerite, 13009, Marseille, France.
Billon E; Department of Medical Oncology, Institut Paoli-Calmettes, Marseille, France.
Finetti P; Laboratory of Predictive Oncology, Department of Medical Oncology, Centre de Recherche en Cancérologie de Marseille (CRCM), Institut Paoli-Calmettes, INSERM UMR1068, CNRS UMR725, Aix-Marseille University, 232 Boulevard Sainte-Marguerite, 13009, Marseille, France.
Sfumato P; Biostatistics Unit, Institut Paoli-Calmettes, Marseille, France.
Monneur A; Department of Medical Oncology, Institut Paoli-Calmettes, Marseille, France.
Pécheux C; Department of Medical genetics, Hôpital Timone Enfants, AP-HM, Marseille, France.
Khran M; Department of Medical genetics, Hôpital Timone Enfants, AP-HM, Marseille, France.; Aix-Marseille University, Inserm, U1251-MMG, Marseille Medical Genetics, Marseille, France.
Brunelle S; Department of Imaging, Institut Paoli-Calmettes, Marseille, France.
Mescam L; Department of Biopathology, Institut Paoli-Calmettes, Marseille, France.
Thomassin-Piana J; Department of Biopathology, Institut Paoli-Calmettes, Marseille, France.
Poizat F; Department of Biopathology, Institut Paoli-Calmettes, Marseille, France.
Charafe-Jauffret E; Department of Biopathology, Institut Paoli-Calmettes, Marseille, France.
Turrini O; Department of Surgical Oncology, Institut Paoli-Calmettes, Marseille, France.
Lambaudie E; Department of Surgical Oncology, Institut Paoli-Calmettes, Marseille, France.
Provansal M; Department of Medical Oncology, Institut Paoli-Calmettes, Marseille, France.
Extra JM; Department of Medical Oncology, Institut Paoli-Calmettes, Marseille, France.
Madroszyk A; Department of Medical Oncology, Institut Paoli-Calmettes, Marseille, France.
Gilabert M; Department of Medical Oncology, Institut Paoli-Calmettes, Marseille, France.
Sabatier R; Department of Medical Oncology, Institut Paoli-Calmettes, Marseille, France.
Vicier C; Department of Medical Oncology, Institut Paoli-Calmettes, Marseille, France.
Mamessier E; Laboratory of Predictive Oncology, Department of Medical Oncology, Centre de Recherche en Cancérologie de Marseille (CRCM), Institut Paoli-Calmettes, INSERM UMR1068, CNRS UMR725, Aix-Marseille University, 232 Boulevard Sainte-Marguerite, 13009, Marseille, France.
Chabannon C; Biobank, Department of Hematology, Institut Paoli-Calmettes, Marseille, France.
Pakradouni J; Department of Clinical Research and Innovation, Institut Paoli-Calmettes, Marseille, France.
Viens P; Department of Medical Oncology, Institut Paoli-Calmettes, Marseille, France.
André F; Department of Medical Oncology, Gustave Roussy Cancer Campus, UMR981 Inserm, Villejuif, France.; Paris Sud University, Orsay, France.
Gravis G; Department of Medical Oncology, Institut Paoli-Calmettes, Marseille, France.
Popovici C; Department of Oncogenetics, Institut Paoli-Calmettes, Marseille, France.
Birnbaum D; Laboratory of Predictive Oncology, Department of Medical Oncology, Centre de Recherche en Cancérologie de Marseille (CRCM), Institut Paoli-Calmettes, INSERM UMR1068, CNRS UMR725, Aix-Marseille University, 232 Boulevard Sainte-Marguerite, 13009, Marseille, France.
Chaffanet M; Laboratory of Predictive Oncology, Department of Medical Oncology, Centre de Recherche en Cancérologie de Marseille (CRCM), Institut Paoli-Calmettes, INSERM UMR1068, CNRS UMR725, Aix-Marseille University, 232 Boulevard Sainte-Marguerite, 13009, Marseille, France.
Pokaż więcej
Źródło:
Genome medicine [Genome Med] 2021 May 18; Vol. 13 (1), pp. 87. Date of Electronic Publication: 2021 May 18.
Typ publikacji:
Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Biomarkers, Tumor*
Genomics*/methods
High-Throughput Nucleotide Sequencing*
Neoplasms/*diagnosis
Neoplasms/*genetics
Adult ; Aged ; Aged, 80 and over ; Biopsy ; Combined Modality Therapy ; Comparative Genomic Hybridization ; Disease Management ; Disease Susceptibility ; Female ; Genetic Variation ; Humans ; Male ; Middle Aged ; Molecular Diagnostic Techniques/methods ; Molecular Diagnostic Techniques/standards ; Neoplasm Grading ; Neoplasm Staging ; Neoplasms/mortality ; Neoplasms/therapy ; Precision Medicine/methods ; Prognosis ; Prospective Studies ; Treatment Outcome ; Young Adult
Czasopismo naukowe
Tytuł:
Claudin-low breast cancers: clinical, pathological, molecular and prognostic characterization.
Autorzy:
Sabatier R
Finetti P
Guille A
Adelaide J
Chaffanet M
Viens P
Birnbaum D
Bertucci F; Department of Molecular Oncology, Centre de Recherche en Cancérologie de Marseille, UMR1068 Inserm, Institut Paoli-Calmettes (IPC), Marseille, France. .
Pokaż więcej
Źródło:
Molecular cancer [Mol Cancer] 2014 Oct 02; Vol. 13, pp. 228. Date of Electronic Publication: 2014 Oct 02.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Breast Neoplasms/*genetics
Breast Neoplasms/*pathology
Claudins/*metabolism
Breast Neoplasms/classification ; Breast Neoplasms/metabolism ; Claudins/genetics ; Disease-Free Survival ; Female ; Gene Expression Profiling ; Gene Expression Regulation, Neoplastic ; Genome, Human/genetics ; Humans ; Middle Aged ; Odds Ratio ; Prognosis ; Proportional Hazards Models ; RNA, Messenger/genetics ; RNA, Messenger/metabolism
Czasopismo naukowe
Tytuł:
Signaling pathway switch in breast cancer.
Autorzy:
Guille A; Centre de Recherche en Cancérologie de Marseille, Oncologie Moléculaire, 'Equipe labellisée Ligue Contre le Cancer', UMR1068 Inserm, CNRS UMR7258, Institut Paoli-Calmettes, Aix-Marseille Université, 27 bd, Leï Roure, BP 30059, Marseille 13273, France. .
Chaffanet M
Birnbaum D
Pokaż więcej
Źródło:
Cancer cell international [Cancer Cell Int] 2013 Jun 27; Vol. 13 (1), pp. 66. Date of Electronic Publication: 2013 Jun 27.
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
Ethnic and racial-specific differences in levels of centrosome-associated mitotic kinases, proliferative and epithelial-to-mesenchymal markers in breast cancers.
Autorzy:
Rivera-Rivera, Yainyrette (AUTHOR)
Vargas, Geraldine (AUTHOR)
Jaiswal, Neha (AUTHOR)
Núñez-Marrero, Angel (AUTHOR)
Li, Jiannong (AUTHOR)
Chen, Dung-Tsa (AUTHOR)
Eschrich, Steven (AUTHOR)
Rosa, Marilin (AUTHOR)
Johnson, Joseph O. (AUTHOR)
Dutil, Julie (AUTHOR)
Chellappan, Srikumar P. (AUTHOR)
Saavedra, Harold I. (AUTHOR)
Pokaż więcej
Źródło:
Cell Division. 12/9/2022, Vol. 17 Issue 1, p1-14. 14p.
Czasopismo naukowe
Tytuł:
Combinatorial targeting of menin and the histone methyltransferase DOT1L as a novel therapeutic strategy for treatment of chemotherapy-resistant ovarian cancer.
Autorzy:
Alexandrova, Elena (AUTHOR)
Lamberti, Jessica (AUTHOR)
Memoli, Domenico (AUTHOR)
Quercia, Claudia (AUTHOR)
Melone, Viola (AUTHOR)
Rizzo, Francesca (AUTHOR)
Tarallo, Roberta (AUTHOR)
Giurato, Giorgio (AUTHOR)
Nassa, Giovanni (AUTHOR)
Weisz, Alessandro (AUTHOR)
Pokaż więcej
Źródło:
Cancer Cell International. Dec2022, Vol. 22 Issue 1, p1-13. 13p.
Czasopismo naukowe
Tytuł:
Genome profiling of ERBB2-amplified breast cancers.
Autorzy:
Sircoulomb F; Marseille Cancer Research Center, UMR891 Inserm, Institut Paoli-Calmettes, Department of Molecular Oncology, Marseille, France.
Bekhouche I
Finetti P
Adélaïde J
Ben Hamida A
Bonansea J
Raynaud S
Innocenti C
Charafe-Jauffret E
Tarpin C
Ben Ayed F
Viens P
Jacquemier J
Bertucci F
Birnbaum D
Chaffanet M
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2010 Oct 08; Vol. 10, pp. 539. Date of Electronic Publication: 2010 Oct 08.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Gene Expression Profiling*
Genome, Human*
Breast Neoplasms/*genetics
Breast Neoplasms/*metabolism
Receptor, ErbB-2/*biosynthesis
Receptor, ErbB-2/*genetics
Adenocarcinoma/metabolism ; Cell Line, Tumor ; Cohort Studies ; Female ; Humans ; Immunohistochemistry/methods ; In Situ Hybridization, Fluorescence ; Nucleic Acid Hybridization ; Oligonucleotide Array Sequence Analysis ; Phosphorylation ; Treatment Outcome
Czasopismo naukowe
Tytuł:
Loss, mutation and deregulation of L3MBTL4 in breast cancers.
Autorzy:
Addou-Klouche L; Marseille Cancer Research Center, Department of Molecular Oncology, UMR891 Inserm, Institut Paoli-Calmettes, Marseille, France.
Adélaïde J
Finetti P
Cervera N
Ferrari A
Bekhouche I
Sircoulomb F
Sotiriou C
Viens P
Moulessehoul S
Bertucci F
Birnbaum D
Chaffanet M
Pokaż więcej
Źródło:
Molecular cancer [Mol Cancer] 2010 Aug 10; Vol. 9, pp. 213. Date of Electronic Publication: 2010 Aug 10.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Down-Regulation*
Mutation*
Breast Neoplasms/*genetics
Base Sequence ; Chromosomes, Human, Pair 11 ; DNA Primers ; Female ; Humans ; Nucleic Acid Hybridization ; RNA, Messenger/genetics
Czasopismo naukowe
Tytuł:
Genome profiling of chronic myelomonocytic leukemia: frequent alterations of RAS and RUNX1 genes.
Autorzy:
Gelsi-Boyer V; Centre de Recherche en Cancérologie de Marseille, Laboratoire d'Oncologie Moléculaire, UMR891 Inserm, Institut Paoli-Calmettes, Marseille, France. />Trouplin V
Adélaïde J
Aceto N
Remy V
Pinson S
Houdayer C
Arnoulet C
Sainty D
Bentires-Alj M
Olschwang S
Vey N
Mozziconacci MJ
Birnbaum D
Chaffanet M
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2008 Oct 16; Vol. 8, pp. 299. Date of Electronic Publication: 2008 Oct 16.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Gene Expression Profiling*
Core Binding Factor Alpha 2 Subunit/*genetics
Genes, ras/*genetics
Leukemia, Myelomonocytic, Chronic/*genetics
Chromosomes, Human, Pair 21 ; Comparative Genomic Hybridization ; Humans ; Leukemia, Myelomonocytic, Chronic/pathology ; Mutation ; Oncogene Proteins, Fusion/genetics ; Sequence Analysis, DNA ; Signal Transduction/genetics ; Ubiquitin Thiolesterase/genetics
Czasopismo naukowe
Tytuł:
Frequency, prognostic impact, and subtype association of 8p12, 8q24, 11q13, 12p13, 17q12, and 20q13 amplifications in breast cancers.
Autorzy:
Letessier A; Centre de Recherche en Cancérologie de Marseille, Département d'Oncologie Moléculaire, UMR599 Inserm/Institut Paoli-Calmettes, Marseille, France. <>
Sircoulomb F
Ginestier C
Cervera N
Monville F
Gelsi-Boyer V
Esterni B
Geneix J
Finetti P
Zemmour C
Viens P
Charafe-Jauffret E
Jacquemier J
Birnbaum D
Chaffanet M
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2006 Oct 13; Vol. 6, pp. 245. Date of Electronic Publication: 2006 Oct 13.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Chromosomes, Human, Pair 11*
Chromosomes, Human, Pair 12*
Chromosomes, Human, Pair 17*
Chromosomes, Human, Pair 20*
Chromosomes, Human, Pair 8*
Gene Amplification*
Breast Neoplasms/*genetics
Carcinoma/*genetics
Adult ; Aged ; Aged, 80 and over ; Biomarkers ; Female ; Gene Frequency ; Humans ; Middle Aged ; Models, Biological ; Neoplasm Metastasis/diagnosis ; Prognosis ; Statistics as Topic
Czasopismo naukowe
Tytuł:
C2orf40 inhibits metastasis and regulates chemo-resistance and radio-resistance of nasopharyngeal carcinoma cells by influencing cell cycle and activating the PI3K/AKT/mTOR signaling pathway.
Autorzy:
Xie, Zuozhong (AUTHOR)
Li, Wei (AUTHOR)
Ai, Jingang (AUTHOR)
Xie, Jun (AUTHOR)
Zhang, Xiaowei (AUTHOR)
Pokaż więcej
Źródło:
Journal of Translational Medicine. 6/8/2022, Vol. 20 Issue 1, p1-18. 18p.
Czasopismo naukowe
Tytuł:
Identification of a novel HOOK3-FGFR1 fusion gene involved in activation of the NF-kappaB pathway.
Autorzy:
Zhang, Xuehong (AUTHOR)
Wang, Furong (AUTHOR)
Yan, Fanzhi (AUTHOR)
Huang, Dan (AUTHOR)
Wang, Haina (AUTHOR)
Gao, Beibei (AUTHOR)
Gao, Yuan (AUTHOR)
Hou, Zhijie (AUTHOR)
Lou, Jiacheng (AUTHOR)
Li, Weiling (AUTHOR)
Yan, Jinsong (AUTHOR)
Pokaż więcej
Źródło:
Cancer Cell International. 1/26/2022, Vol. 22 Issue 1, p1-12. 12p.
Czasopismo naukowe
Tytuł:
Molecular profiling of advanced malignancies guides first-line N-of-1 treatments in the I-PREDICT treatment-naïve study.
Autorzy:
Sicklick, Jason K. (AUTHOR)
Kato, Shumei (AUTHOR)
Okamura, Ryosuke (AUTHOR)
Patel, Hitendra (AUTHOR)
Nikanjam, Mina (AUTHOR)
Fanta, Paul T. (AUTHOR)
Hahn, Michael E. (AUTHOR)
De, Pradip (AUTHOR)
Williams, Casey (AUTHOR)
Guido, Jessica (AUTHOR)
Solomon, Benjamin M. (AUTHOR)
McKay, Rana R. (AUTHOR)
Krie, Amy (AUTHOR)
Boles, Sarah G. (AUTHOR)
Ross, Jeffrey S. (AUTHOR)
Lee, J. Jack (AUTHOR)
Leyland-Jones, Brian (AUTHOR)
Lippman, Scott M. (AUTHOR)
Kurzrock, Razelle (AUTHOR)
Pokaż więcej
Źródło:
Genome Medicine. 10/4/2021, Vol. 13 Issue 1, p1-14. 14p.
Czasopismo naukowe
Tytuł:
Clinical impact of PD-L1 expression in triple-negative breast cancer patients with residual tumor burden after neoadjuvant chemotherapy.
Autorzy:
Oner, Gizem (AUTHOR)
Önder, Semen (AUTHOR)
Karatay, Hüseyin (AUTHOR)
Ak, Naziye (AUTHOR)
Tükenmez, Mustafa (AUTHOR)
Müslümanoğlu, Mahmut (AUTHOR)
İğci, Abdullah (AUTHOR)
Dincçağ, Ahmet (AUTHOR)
Özmen, Vahit (AUTHOR)
Aydiner, Adnan (AUTHOR)
Yavuz, Ekrem (AUTHOR)
Cabioğlu, Neslihan (AUTHOR)
Pokaż więcej
Źródło:
World Journal of Surgical Oncology. 9/2/2021, Vol. 19 Issue 1, p1-9. 9p.
Czasopismo naukowe
Tytuł:
Establishment of a novel CNV-related prognostic signature predicting prognosis in patients with breast cancer.
Autorzy:
Hu, Wei (AUTHOR)
Li, Mingyue (AUTHOR)
Zhang, Qi (AUTHOR)
Liu, Chuan (AUTHOR)
Wang, Xinmei (AUTHOR)
Li, Jing (AUTHOR)
Qiu, Shusheng (AUTHOR)
Li, Liang (AUTHOR)
Pokaż więcej
Źródło:
Journal of Ovarian Research. 8/8/2021, Vol. 14 Issue 1, p1-14. 14p.
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies